Study of a 12-Week Program Combining Physical Activity, Nutrition, and Supportive Care to Improve Quality of Life in Women After Breast Cancer
Led by Siel Bleu · Updated on 2025-07-16
160
Participants Needed
8
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness of an integrative program called ADA, which combines physical activity, nutrition, and supportive care to improve the quality of life for women who have survived breast cancer. This pragmatic cluster randomized trial compares the ADA intervention to usual care and aims to provide evidence on how well such interventions work in real-life settings. The study particularly focuses on women who have completed most cancer treatments but may still be experiencing long-term effects affecting their physical and mental health.
The ADA intervention consists of a 12-week program featuring one-hour adapted physical activity sessions combined with relaxation and deep breathing exercises. Participants receive short nutrition information sheets, attend workshops on mobility and nutrition, set personal motivational challenges, and receive follow-up calls for support and individualization. They also have access to an online space with helpful resources. The control group will receive usual care involving weekly adapted physical activity sessions based on current recommendations for cancer survivors.
Participants will be involved for at least 12 months, with assessments at 3, 6, and 12 months after starting the intervention. Researchers will measure health-related quality of life as the primary outcome at 12 months, along with secondary outcomes including physical activity levels, fatigue, motivation, sedentary behavior, relationship to food, and self-efficacy. The study includes group activities, questionnaires, and motivational check-ins to monitor progress and adherence throughout the trial.
CONDITIONS
Brief Title
Program of Physical Activity, Nutrition and Supportive to Improve the Quality of Life of Breast Cancer Survivors
Research Team
N
Nicolas Deschamps
G
Gwenn Menvielle, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsor
Who Can Participate
Age: 18Years - 72Years
FEMALE
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Adult women between 18 and 72 years of age
Diagnosed with localized breast cancer of any type
Completed surgery, chemotherapy, and radiotherapy within the last 15 months, or currently undergoing hormone therapy or nearing the end of Herceptin treatment
French-speaking
Covered by the French Social Security system or similar health insurance
You will not qualify if you...
Diagnosis of cancer other than breast cancer, or breast cancer relapse or metastasis, or generalized cancer
Medical contraindication to exercise (a medical certificate is required)
Significant visual, auditory, or behavioral problems preventing participation in group physical activity
Planning to move away from the study site
Participating in another clinical trial
Male sex
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - 12 weeks
Participants engage in a 12-week program involving adapted physical activity sessions, nutrition information, relaxation techniques, and motivational support, or receive usual care consisting of weekly adapted physical activity sessions based on current practices.
Weekly visits for 12 weeks
Follow-up
Duration - Up to 12 months after the beginning of the intervention
Participants are assessed on health-related quality of life, physical, social, emotional, and functional well-being, fatigue, physical activity level, motivation, sedentary behavior, relationship to food, and self-efficacy at several timepoints after the intervention.
Visits at 3 months, 6 months, and 12 months after the beginning of the intervention
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Studying Key Non-coding RNAs and Their Interaction With Chromatin Remodeling in Breast Cancer Patients
Comparing 18F-FDG and 68Ga-FAPI-46 PET Scans in Women With ER-positive Breast Cancer
Evaluating 18F-T2 PETCT Imaging for Detecting Tumors with High CAIX Levels in Adults
Comparing 3-Needle and 5-Needle Genicular Nerve Blocks for Pain and Quality of Life in Knee Osteoarthritis
Observational Study Comparing 3D and 2D Echocardiography for Early Heart Damage Detection in Patients Receiving Anthracyclines and HER2-Targeted Cancer Therapies
Study Comparing 3D-Printed Biodegradable Breast Implants, Traditional Breast-Conserving Surgery, and Silicone Implant Reconstruction for Breast Cancer Patients
Ultrahypofractionated 5-Session Whole Breast Radiotherapy with Boost versus Standard 15-Session Radiotherapy for Breast Cancer Patients with Unfavorable Characteristics
Phase II Study Comparing 5-Day vs. 9-Day Whole Breast Radiotherapy with Boost in Early-stage Breast Cancer
Evaluating 68Ga-FAPI PETCT for Checking Axillary Lymph Node Status After Neoadjuvant Therapy in Women with Breast Cancer
PETCT Imaging Using 68Ga-RM26-RGD to Detect Breast, Brain, and Prostate Tumors with GRPR and v3 Receptors
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effectiveness of a community-based multicomponent lifestyle intervention (the ADA programme) to improve the quality of life of French breast cancer survivors: protocol for a pragmatic cluster randomised trial and embedded qualitative study.
Fabienne El-Khoury, Jean-Christophe Mino, Nicolas Deschamps...